Tretten

Drug List

Tretten

Drug Name

Tretten (Coagulation factor Xlll A-Subunit (recombinant))

Manufactured By

Novo Nordisk Pharmaceuticals, Inc.

Drug Savings

Nationwide Prescription Connection (NPC) is an experienced advocacy service that helps connect patients to manufacturer provided free and discount programs. We can help the uninsured, under insured, those in the Medicare gap also known as the "doughnut hole", or even those needing help with expensive co-pays.  Our web site makes it easy for you to enter the medications you are taking, along with some basic patient information, and then finds the program that is right for you.

Nationwide Prescription Connection (NPC) is an experienced advocacy service that helps connect patients to manufacturer provided free and discount programs. We can help the uninsured, under insured, those in the Medicare gap also known as the "doughnut hole", or even those needing help with expensive co-pays.  Our web site makes it easy for you to enter the medications you are taking, along with some basic patient information, and then finds the program that is right for you.

Treats Disease/Condition

Uses

TRETTEN, Coagulation Factor XIII A-Subunit (Recombinant), is indicated for routine prophylaxis for bleeding in patients with congenital factor XIII A-subunit deficiency. TRETTEN is not for use in patients with congenital factor XIII B-subunit deficiency

How To Use

Treatment should be initiated under the supervision of a physician experienced in the treatment of rare bleeding disorders.

Side Effects

The most common adverse reactions reported in clinical trials (≥1%), were headache, pain in the extremities, injection site pain, and increase in fibrin D dimer levels.

Drug Interactions

Thrombosis may occur if TRETTEN is administered concomitantly with factor VIIa

In Case of Overdose

One patient accidentally received a dose 2.3 times the recommended dose. No clinical signs and symptoms were observed

In Case of Missed Dose

Storage